Print    Email
Decrease (-) Restore Default Increase (+)

Clinical Trials

Treatment   Cardiology
Trial Title   Study to Evaluate the Safety and Efficacy of SCH 530384 in Addition to Standard of Care in Subjects with a History of Atherosclerotic Disease: thrombin Receptor Antagonist i Secondary Prevention of Atherothrombotic Ischemic Events
Description of Research   The purpose of the study is to test the safety and effectiveness of an investigational drug that blocks platelets and may reduce the risk of heart attack or stroke, when used with standard medications that your doctor has decided you will receive for treatment of your atherosclerosis.
Study Number   HSR 07-0846
Inclusion/Notes   Subject may be of either sex and any race, and must be at least 18 years old.
Subject must have evidence or a history of atherosclerosis involving the coronary, cerebral, or peripheral vascular systems
Principal Investigator   Qureshi MD, Mansoor A
Contact Name   Marentette RN, Cheryl
Fax   (734) 712-7244
Phone   (734) 712-8000
A Member of Trinity Health
© 2015 Trinity Health

St. Joseph Mercy Ann Arbor | 5301 McAuley Drive, Ypsilanti, MI 48197 | 734-712-3456